On Monday, Following Stocks were among the “Top 100 Losers” of U.S. Stock Market: JD.com, Inc. (NASDAQ:JD), Altera Corp. (NASDAQ:ALTR), Endeavour Silver Corp. (NYSE:EXK), BioTelemetry, Inc. (NASDAQ:BEAT)
JD.com, Inc. (NASDAQ:JD), with shares declined -1.10%, closed at $29.75.
Altera Corp. (NASDAQ:ALTR), with shares dropped -3.54%, settled at $42.82.
Endeavour Silver Corp. (NYSE:EXK), with shares dipped -3.47%, and closed at $1.95.
BioTelemetry, Inc. (NASDAQ:BEAT), plummeted -3.41%, and closed at $8.79.
Latest NEWS regarding these Stocks are depicted underneath:
JD.com, Inc. (NASDAQ:JD)
Formerly on March 10, JD.com, Inc. (JD), declared that it will offer the new Apple Watch and 12-inch Macbook for sale through the JD.com website and through its Weixin entry point starting on April 24, simultaneously with the launch of sales in Apple Stores in Mainland China.
JD.com began taking pre-orders for the Macbook recently, while customers will be able to pre-order the Apple Watch starting on April 10.
Beijing Jingdong Century Trading Co., Ltd. operates as an online retailer in China. It retails various categories of products to customers worldwide. The corporation was founded in 1998 and is based in Shanghai, China.
Altera Corp. (NASDAQ:ALTR)
Formerly on March 16, Altera Corp. (ALTR), declared that a new Avaya Scopia videoconferencing system takes advantage of Altera’s powerful H.265 video codec solution, which is capable of handling full duplex encoding and decoding on a single FPGA, enabling best-in-class videoconferencing. The new Altera H.265 codec enables multi-channel support for today’s 1080p60 resolutions on a single, low-power chip; the device will also manage 4K video. Avaya declared the addition to its Team Engagement videoconferencing portfolio, the Avaya Scopia XT7100, which uses Altera’s H.265 solution, on March 11.
Altera’s advanced technology combines high-end FPGA hardware and IP (software) to deliver a high performance H.265 codec that enables the “heavy-lifting” required in videoconferencing—encoding the live streams to enable superior picture quality with ultra-low video latency.
Altera Corporation, a semiconductor corporation, designs and sells programmable logic devices (PLDs), HardCopy application-specific integrated circuit (ASIC) devices, power system-on-chip devices (PowerSoCs), pre-defined design building blocks, and associated development tools.
Endeavour Silver Corp. (NYSE:EXK)
Formerly on March 17, Endeavour Silver Corp. (EXK), initiated a major expansion of its El Cubo mine in Guanajuato state, Mexico. The Corporation plans to ramp up mine output over the next four months from 1,550 tonnes per day (tpd), the current El Cubo plant capacity, to 2,200 tpd.
The additional 650 tpd of mine production at El Cubo will come primarily from the V-Asunción mine area, which has thicker mineralized zones amenable to long hole mining, and the Santa Cecilia mine area, which has narrower but higher grade veins, and will be processed at Endeavour’s Bolañitos plant, located 18 kilometers away in the same district, which has accessible capacity and comparable circuits to El Cubo. Production at Bolañitos will be reduced by a small amount to accommodate more processing of El Cubo ore.
The main reason for the mine expansion is to drive operating costs lower and generate free cash flow at El Cubo by taking advantage of the accessible plant capacity at Bolañitos. As a result, El Cubo will become the Corporation’s largest mine by metal production. Endeavour received the cooperation of the miners’ union at El Cubo last week in finalizing a labour contract that facilitates the mine expansion and assists establish the short- and long-term viability of the mine.
Endeavour Silver Corp., a Canadian mineral corporation, engages in the evaluation, attainment, exploration, development, and exploitation of precious metal properties in Mexico and Chile. It produces silver-gold from its underground mines.
BioTelemetry, Inc. (NASDAQ:BEAT)
BioTelemetry, Inc. (BEAT), declared the completion of the Department of Justice investigation with the signing of a settlement contract between the two parties. Per the contract, BioTelemetry will pay $6.4 million to the Department of Justice, which was reflected in the Corporation’s 2014 financial statements.
The settlement relates to allegations that BioTelemetry encouraged physicians to use two non-specified diagnosis codes to ensure coverage of mobile cardiac telemetry between November 2008 and June 2011. It is the Corporation’s belief that physicians utilized these non-specified codes for palpitations, a diagnosis that was permitted under the local coverage determination but for which no corresponding diagnosis code was offered. On June 29, 2011, Medicare eliminated this ambiguity by adding a specific diagnosis code for palpitations and removing the two non-specified diagnosis codes.
BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
